BDBM385532 (1R,6S or 1S, 6R)-4- ((S or R)-1-(2-chloro- 6-(1- (trifluoromethyl)cyclo- propyl)benzoyl)-6- (3-methoxyazetidine- 1-carbonyl)-4,5,6,7- tetrahydro-1H- indazol-3-yl)-6- methylcyclohex-3- ene-1-carboxylic acid::US10287272, Example 17D::US10287272, Example 17E::US10689369, Example 17E

SMILES COC1CN(C(=O)C2CCc3c(C4=CC[C@@H](C(=O)O)[C@@H](C)C4)nn(C(=O)c4c(Cl)cccc4C4(C(F)(F)F)CC4)c3C2)C1

InChI Key InChIKey=NEGMILSFVWIQIL-UHFFFAOYSA-N

Data  4 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 4 hits for monomerid = 385532   

TargetNuclear receptor ROR-gamma(Human)
Merck Sharp & Dohme

US Patent
LigandChemical structure of BindingDB Monomer ID 385532BDBM385532(US10287272, Example 17E | (1R,6S or 1S, 6R)-4- ((S...)
Affinity DataIC50: 1nMAssay Description:To identify novel antagonists of RORgammaT, an assay was developed which employs the interaction of RORgammaT with its co-activator peptide SRC1_2. T...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/27/2020
Entry Details
US Patent

TargetNuclear receptor ROR-gamma(Human)
Merck Sharp & Dohme

US Patent
LigandChemical structure of BindingDB Monomer ID 385532BDBM385532(US10287272, Example 17E | (1R,6S or 1S, 6R)-4- ((S...)
Affinity DataIC50: 1nMAssay Description:The compounds of the invention inhibit RORgammaT activity. Activation of RORgammaT activity can be measured using, e.g., biochemical TR-FRET assay. I...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/22/2021
Entry Details
US Patent

TargetNuclear receptor ROR-gamma(Human)
Merck Sharp & Dohme

US Patent
LigandChemical structure of BindingDB Monomer ID 385532BDBM385532(US10287272, Example 17E | (1R,6S or 1S, 6R)-4- ((S...)
Affinity DataIC50: 2nMAssay Description:To identify novel antagonists of RORgammaT, an assay was developed which employs the interaction of RORgammaT with its co-activator peptide SRC1_2. T...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/27/2020
Entry Details
US Patent

TargetNuclear receptor ROR-gamma(Human)
Merck Sharp & Dohme

US Patent
LigandChemical structure of BindingDB Monomer ID 385532BDBM385532(US10287272, Example 17E | (1R,6S or 1S, 6R)-4- ((S...)
Affinity DataIC50: 2nMAssay Description:The compounds of the invention inhibit RORgammaT activity. Activation of RORgammaT activity can be measured using, e.g., biochemical TR-FRET assay. I...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/22/2021
Entry Details
US Patent